- Home
- BIAF vs AGL Comparison
BIAF vs AGL Comparison
Compare BIAF & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIAF | AGL |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | 57 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 5.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BIAF | AGL |
|---|---|---|
| Price | $1.92 | $71.90 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $55.68 |
| AVG Volume (30 Days) | 363.4K | ★ 559.5K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.94 |
| Revenue | N/A | ★ $5,932,576,000.00 |
| Revenue This Year | $20.95 | N/A |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | ★ N/A | $23.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $0.30 |
| 52 Week High | $13.50 | $72.39 |
Technical Indicators
Market Signals| Indicator | BIAF | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 37.73 | 82.85 |
| Support Level | $1.23 | $0.63 |
| Resistance Level | $3.58 | N/A |
| Average True Range (ATR) | 0.23 | 6.18 |
| MACD | -0.05 | 3.95 |
| Stochastic Oscillator | 8.91 | 93.54 |
Price Performance
Historical ComparisonAbout BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About AGL agilon health inc.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.